Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SERA | US
0.05
2.00%
Healthcare
Diagnostics & Research
30/06/2024
05/06/2026
2.29
2.27
2.33
2.18
Sera Prognostics Inc. a women's health diagnostic company discovers develops and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions including preeclampsia molecular time-to-birth gestational diabetes mellitus fetal growth restriction stillbirth and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City Utah.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
95.5%1 month
92.4%3 months
82.7%6 months
76.9%-
-
4.28
0.02
0.02
-0.61
1.93K
-
-34.53M
76.41M
76.41M
-
-38.55K
-
-80.50
-44.77
8.09
3.45
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.70
Range1M
0.81
Range3M
0.90
Rel. volume
0.40
Price X volume
76.64K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc | ANIX | Diagnostics & Research | 2.48 | 79.81M | -5.34% | n/a | 1.09% |
| ENDRA Life Sciences Inc | NDRA | Diagnostics & Research | 4.23 | 77.79M | -11.32% | n/a | 3.13% |
| CCLD | CCLD | Health Information Services | 2.35 | 39.75M | -2.08% | n/a | 20.40% |
| Neuronetics Inc | STIM | Diagnostics & Research | 1.29 | 39.09M | -11.64% | n/a | 323.03% |
| STAR EQUITY HOLDINGS INC | STRR | Diagnostics & Research | 11.3 | 36.40M | -3.00% | n/a | 26.85% |
| Aclarion Inc | ACON | Health Information Services | 3.57 | 35.86M | 1.13% | n/a | 47.32% |
| Biomerica Inc | BMRA | Diagnostics & Research | 2.12 | 35.66M | -1.17% | n/a | 13.22% |
| Precipio Inc | PRPO | Diagnostics & Research | 23.49 | 34.82M | 0.56% | n/a | 9.66% |
| MDxHealth SA | MDXH | Diagnostics & Research | 0.5659 | 26.76M | -5.68% | n/a | -643.01% |
| Cytosorbents Corporation | CTSO | Diagnostics & Research | 0.459 | 24.98M | -5.94% | n/a | 159.92% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Reading International Inc | RDIB | Media - Diversified | 8.6 | 67.46M | 0.00% | n/a | 4054.78% |
| ILAG | ILAG | Building Products & Equipment | 3.5 | 63.21M | 1.16% | n/a | 5.48% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 5.87 | 55.88M | -3.61% | n/a | 19.98% |
| Reading International Inc | RDI | Media - Diversified | 1.18 | 33.31M | 0.85% | n/a | 4054.78% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.02 | 14.90M | -4.67% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.428 | 8.27M | 2.39% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.32 | 3.37M | -13.16% | n/a | 17.32% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.3876 | 213.57K | -7.71% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.61 | 12.67 | Cheaper |
| Ent. to Revenue | 1,928.54 | 44.00 | Expensive |
| PE Ratio | - | 40.09 | - |
| Price to Book | 4.28 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 82.69 | 59.59 | Riskier |
| Debt to Equity | 0.02 | -14.36 | Expensive |
| Debt to Assets | 0.02 | 0.34 | Cheaper |
| Market Cap | 76.41M | 13.71B | Emerging |